Related Experiment Video
Updated: Aug 18, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor
Xiaoli Tang1, Xuemin Wang, Xiaoming Gong
1Department of Medicine, Rhode Island Hospital and Brown Medical School, Providence, Rhode Island 02903, USA.
Abstract:
Regulation of the process of neuronal death plays a central role both during development of the CNS and in adult brain. The transcription factor myocyte enhancer factor 2 (MEF2) plays a critical role in neuronal survival. Cyclin-dependent kinase 5 (Cdk5) mediates neurotoxic effects by phosphorylating and inhibiting MEF2. How Cdk5-dependent phosphorylation reduces MEF2 transactivation activity remained unknown. Here, we demonstrate a novel mechanism by which Cdk5, in conjunction with caspase, inhibits MEF2. Using primary cerebellar granule neuron as a model, our investigation reveals that neurotoxicity induces destabilization of MEF2s in neurons. Destabilization of MEF2 is caused by an increase in caspase-dependent cleavage of MEF2. This cleavage event requires nuclear activation of Cdk5 activity. Phosphorylation by Cdk5 alone is sufficient to promote degradation of MEF2A and MEF2D by caspase-3. In contrast to MEF2A and MEF2D, MEF2C is not phosphorylated by Cdk5 after glutamate exposure and, therefore, resistant to neurotoxin-induced caspase-dependent degradation. Consistently, blocking Cdk5 or enhancing MEF2 reduced toxin-induced apoptosis. These findings define an important regulatory mechanism that for the first time links prodeath activities of Cdk5 and caspase. The convergence of Cdk5 phosphorylation-dependent caspase-mediated degradation of nuclear survival factors exemplified by MEF2 may represent a general process applicable to the regulation of other survival factors under diverse neurotoxic conditions.
Insights
Cyclin-dependent kinase 5 (Cdk5) and caspase collaborate to trigger neuronal death by degrading the survival factor myocyte enhancer factor 2 (MEF2). This Cdk5-MEF2-caspase pathway offers a new target for neuroprotection.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Death Regulation
Background:
- Neuronal death regulation is crucial for CNS development and adult brain function.
- Myocyte enhancer factor 2 (MEF2) is a key transcription factor promoting neuronal survival.
- Cyclin-dependent kinase 5 (Cdk5) contributes to neurotoxicity by inhibiting MEF2, but the mechanism was unclear.
Purpose of the Study:
- To elucidate the mechanism by which Cdk5-dependent phosphorylation inhibits MEF2 transactivation activity.
- To investigate the interplay between Cdk5, caspase, and MEF2 in neurotoxicity.
Main Methods:
- Primary cerebellar granule neurons were used as a model system.
- Investigated MEF2 destabilization and cleavage in response to neurotoxicity.
- Assessed the role of Cdk5 activity and phosphorylation in MEF2 degradation by caspase-3.
- Examined the differential effects on MEF2A, MEF2D, and MEF2C isoforms.
Main Results:
- Neurotoxicity induces caspase-dependent cleavage and destabilization of MEF2.
- Cdk5 activation is required for this cleavage event.
- Cdk5 phosphorylation of MEF2A and MEF2D promotes their degradation by caspase-3.
- MEF2C is resistant to this degradation pathway.
- Inhibition of Cdk5 or enhancement of MEF2 reduced neurotoxin-induced apoptosis.
Conclusions:
- A novel mechanism linking Cdk5 and caspase in MEF2 degradation and neuronal death is identified.
- Cdk5 phosphorylation primes MEF2A/D for caspase-mediated destruction, inhibiting neuronal survival.
- This Cdk5-caspase-MEF2 axis represents a potential therapeutic target for neurodegenerative conditions.
Related Concept Videos
Master Transcription Regulators
Anaphase Promoting Complex
MAPK Signaling Cascades
Mitogens and the Cell Cycle
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Positive Regulator Molecules
